Requirement of cyclin D1 in mesangial cell mitogenesis

Journal of the American Society of Nephrology

Volumn 11, Issue 8, 2000, Pages 1398-1408

  Lang, Stefan ^a   Hartner, Andrea ^a   Sterzel, R Bernd ^a   Schöcklmann, Harald O ^a  

^a UNIVERSITY HOSPITAL ERLANGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; CYCLIN D1; PLATELET DERIVED GROWTH FACTOR RECEPTOR; PROTEIN P21; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL HYPERPLASIA; CELL PROLIFERATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; IMMUNOHISTOCHEMISTRY; MALE; MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS; MESANGIUM CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN TARGETING; RAT;

EID: 0033929064     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (51)

1. Striker LJ, Doi T, Elliot S, Striker GE: The contribution of glomerular mesangial cells to progressive glomerulosclerosis. Semin Nephrol 9: 318-328, 1989
2. Johnson RJ, Raines EW, Floege J, Yoshimura A, Pritzl P, Alpers C, Ross R: Inhibition of mesangial cell proliferation and matrix expansion in glomerulonephritis in the rat by antibody to platelet-derived growth factor. J Exp Med 175: 1413-1416, 1992
3. Pippin JW, Qu Q, Meijer L, Shankland SJ: Direct in vivo inhibition of the nuclear cell cycle cascade in experimental mesangial proliferative glomerulonephritis with Roscovitine, a novel cyclin-dependent kinase antagonist. J Clin Invest 100: 2512-2520, 1997
4. Floege J, Eng E, Young BA, Couser WG, Johnson RJ: Heparin suppresses mesangial cell proliferation and matrix expansion in experimental mesangioproliferative glomerulonephritis. Kidney Int 43: 369-380, 1993
5. Floege J, Topley N, Hoppe J, Barrett TB, Resch K: Mitogenic effect of platelet-derived growth factor in human glomerular mesangial cells: Modulation and/or suppression by inflammatory cytokines. Clin Exp Immunol 86: 334-341, 1991
6. Floege J, Eng E, Young BA, Alpers CE, Barrett TB, Bowen-Pope DF, Johnson RJ: Infusion of platelet-derived growth factor or basic fibroblast growth factor induces selective glomerular mesangial cell proliferation and matrix accumulation in rats. J Clin Invest 92: 2952-2962, 1993
7. Iida H, Seifert R, Alpers CE, Gronwald RG, Phillips PE, Pritzl P, Gordon K, Gown AM, Ross R, Bowen-Pope DF: Platelet-derived growth factor (PDGF) and PDGF receptor are induced in mesangial proliferative nephritis in the rat. Proc Natl Acad Sci USA 88: 6560-6564, 1991
8. Kaname S, Uchida S, Ogata E, Kurokawa K: Autocrine secretion of transforming growth factor-beta in cultured rat mesangial cells. Kidney Int 42: 1319-1327, 1992
9. Shankland SJ, Johnson RJ: TGF-beta in glomerular disease. Miner Electrolyte Metab 24: 168-173, 1998
10. Mazars P, Barboule N, Baldin V, Vidal S, Ducommun B, Valette A: Effects of TGF-beta 1 (transforming growth factor-beta 1) on the cell cycle regulation of human breast adenocarcinoma (MCF-7) cells. FEBS Lett 362: 295-300, 1995
11. Schoecklmann HO, Rupprecht HD, Zauner I, Sterzel RB: TGF-β1-induced cell cycle arrest in renal mesangial cells involves inhibition of cyclin E-cdk2 activation and retinoblastoma protein phosphorylation. Kidney Int 51: 1228-1236, 1997
12. Kitamura M, Burton S, English J, Kawachi H, Fine LG: Transfer of a mutated gene encoding active transforming growth factor-β1 suppresses mitogenesis and IL-1 response in the glomerulus. Kidney Int 48: 1747-1757, 1995
13. 1 cyclins. Cell 73: 1059-1065, 1993
14. 1/S transition [Review]. Cancer Surv 29: 7-23, 1997
15. 1. Genes Dev 7: 812-821, 1993
16. Kato J, Matsushime H, Hiebert SW, Ewen ME, Sherr CJ: Direct binding of cyclin D to the retinoblastoma gene product (pRb) and pRb phosphorylation by the cyclin D-dependent kinase CDK4. Genes Dev 1: 331-342, 1993
17. Weinberg RA: The retinoblastoma protein and cell cycle control. Cell 81: 323-330, 1995
18. La Thangue NB: DRTF1/E2F: An expanding family of heterodimeric transcription factors implicated in cell-cycle control. Trends Biochem Sci 19: 108-114, 1994
19. 1. J Biol Chem 273: 33279-33286, 1998
20. Maridor G, Gallant P, Golsteyn R, Nigg EA: Nuclear localization of vertebrate cyclin A correlates with its ability to form complexes with cdk catalytic subunits. J Cell Sci 106: 535-544, 1993
21. Cheng M, Olivier P, Diehl JA, Fero M, Roussel MF, Roberts JM, Sherr CJ: The p21 (Cip1) and p27 (Kip1) CDK "inhibitors" are essential activators of cyclin D-dependent kinases in murine fibroblasts. EMBO J 18: 1571-1583, 1999
22. Winston JT, Pledger WJ: Growth factor regulation of cyclin D1 mRNA expression through protein synthesis-dependent and -independent mechanisms. Mol Biol Cell 4: 1133-1144, 1993
23. Surmacz E, Reiss K, Sell C, Baserga R: Cyclin D1 messenger RNA is inducible by platelet-derived growth factor in cultured fibroblasts. Cancer Res 52: 4522-4525, 1992
24. Motokura T, Arnold A: Cyclins and oncogenesis. Biochim Biophys Acta 1155: 63-78, 1993
25. Terada Y, Inoshita S, Nakashima O, Yamada T, Tamamori M, Ito H, Sasaki S, Marumo F: Cyclin D1, p16, and retinoblastoma gene regulate mitogenic signaling of endothelin in rat mesangial cells. Kidney Int 53: 76-83, 1998
26. Terada Y, Yamada T, Nakashima O, Tamamori M, Ito H, Sasaki S, Marumo F: Overexpression of cell cycle inhibitors (p16INK4 and p21Cip1) and cyclin D1 using adenovirus vectors regulates proliferation of rat mesangial cells. J Am Soc Nephrol 8: 51-60, 1997
27. 1 cyclin-dependent kinases. Genes Dev 9: 1149-1163, 1995
28. Michieli P, Chedid M, Lin D, Pierce JH, Mercer WE, Givol D: Induction of WAF1/CIP1 by a p53-independent pathway. Cancer Res 54: 3391-3395, 1994
29. Zhang H, Hannon GJ, Beach D: p21 -containing cyclin kinases exist in both active and inactive states. Genes Dev 8: 1750-1758, 1994
30. LaBaer J, Garrett MD, Stevenson LF, Slingerland JM, Sandhu C, Chou HS, Fattaey A, Harlow E: New functional activities for the p21 family of CDK inhibitors. Genes Dev 11: 847-862, 1997
31. Hiyama H, Iavarone A, Reeves SA: Regulation of the cdk inhibitor p21 gene during cell cycle progression is under the control of the transcription factor E2F. Oncogene 16: 1513-1523, 1998
32. Shankland SJ, Hugo C, Coats SR, Nangaku M, Pichler RH, Gordon KL, Pippin J, Roberts JM, Couser WG, Johnson RJ: Changes in cell-cycle protein expression during experimental mesangial proliferative glomerulonephritis. Kidney Int 50: 1230-1239, 1996
33. Morishita R, Gibbons GH, Ellison KE, Nakajima M, von der Leyen H, Zhang L, Kaneda Y, Ogihara T, Dzau VJ: Intimai hyperplasia after vascular injury is inhibited by antisense cdk 2 kinase oligonucleotides. J Clin Invest 93: 1458-1464, 1994
34. Hofer G, Grimmer C, Sukhatme VP, Sterzel RB, Rupprecht HD: Transcription factor Egr-1 regulates glomerular mesangial cell proliferation. J Biol Chem 271: 28306-28310, 1996
35. Maeshima Y, Kashihara N, Sugiyama H, Makino H, Ota Z: Antisense oligonucleotides to proliferating cell nuclear antigen and Ki-67 inhibit human mesangial cell proliferation. J Am Soc Nephrol 7: 2219-2229, 1996
36. Bagchus WM, Hoedemaeker PJ, Rozing J, Bakker WW: Glomerulonephritis induced by monoclonal anti-Thy1.1 antibodies: A sequential histological and ultrastructural study in the rat. Lab Invest 55: 680-687, 1986
37. Rupprecht HD, Dann P, Sukhatme VP, Sterzel RB, Coleman DL: Effect of vasoactive agents on induction of Egr-1 in rat mesangial cells: Correlation with mitogenicity. Am J Physiol 263: F623-F636, 1992
38. Bianchi S, Fabiani S, Muratori M, Arnold A, Sakaguchi K, Miki T, Brandi ML: Calcium modulates the cyclin D1 expression in a rat parathyroid cell line. Biochem Biophys Res Commun 204: 691-700, 1994
39. 1 cyclin and cell cycle inhibitors in experimental glomerulonephritis [Abstract]. J Am Soc Nephrol 7: 1726, 1996
40. Nagata M, Yamaguchi Y, Ito K: Loss of mitotic activity and the expression of vimentin in glomerular epithelial cells of developing human kidneys. Anat Embryol (Berl) 187: 275-279, 1993
41. Nagata M, Nakayama K, Terada Y, Hoshi S, Watanabe T: Cell cycle regulation and differentiation in the human podocyte lineage. Am J Pathol 153: 1511-1520, 1998
42. Ko TC, Sheng HM, Reisman D, Thompson EA, Beauchamp RD: Transforming growth factor-beta 1 inhibits cyclin D1 expression in intestinal epithelial cells. Oncogene 10: 177-184, 1995
43. Satterwhite DJ, Aakre ME, Gorska AE, Moses HL: Inhibition of cell growth by TGF beta 1 is associated with inhibition of B-myb and cyclin A in both BALB/MK and Mv1Lu cells. Cell Growth Differ 5: 789-799, 1994
44. Itoh S, Landstrom M, Hermansson A, Itoh F, Heldin CH, Heldin NE, ten Dijke P: Transforming growth factor β1 induces nuclear export of inhibitory Smad7. J Biol Chem 273: 29195-29201, 1998
45. Taules M, Rodriguez-Vilarrupla A, Rius E, Estanyol JM, Casanovas O, Sacks DB, Perez-Paya E, Bachs O, Agell N: Calmodulin binds to p21 (Cip1) and is involved in the regulation of its nuclear localization. J Biol Chem 274: 24445-24448, 1999
46. 1 arrest and induces apoptosis in human cancer cells. Oncogene 15: 1903-1909, 1997
47. Sofer-Levi Y, Resnitzky D: Apoptosis induced by ectopic expression of cyclin D1 but not cyclin E. Oncogene 13: 2431-2437, 1996
48. kip1, inhibits growth, and enhances apoptosis. Cell Growth Differ 7: 699-710, 1996
49. Datto MB, Yu Y, Wang XF: Functional analysis of the transforming growth factor β responsive elements in the WAF1/Cip1/ p21 promoter. J Biol Chem 270: 28623-28628, 1995
50. Datto MB, Li Y, Panus JF, Howe DJ, Xiong Y, Wang XF: Transforming growth factor beta induces the cyclin-dependent kinase inhibitor p21 through a p53-independent mechanism. Proc Natl Acad Sci USA 92: 5545-5549, 1995
51. Hiyama H, Iavarone A, LaBaer J, Reeves SA: Regulated ectopic expression of cyclin D1 induces transcriptional activation of the cdk inhibitor p21 gene without altering cell cycle progression. Oncogene 14: 2533-2542, 1997